Pulmonary Artery Compliance Device
Pulmonary Arterial Hypertension (WHO Group 1 PH)
Key Facts
About Aria CV
Aria CV is pioneering a unique, purely mechanical implantable device to treat Pulmonary Arterial Hypertension (WHO Group 1 PH), a progressive and deadly cardiovascular condition. Its core technology mimics the natural elasticity of a healthy pulmonary artery, using a gas-filled balloon and reservoir system driven by the heart's own motion to improve vascular compliance and cardiac efficiency. The company has completed an acute first-in-human study and is led by a seasoned medical device CEO alongside its scientific founders. As an investigational-stage company, Aria CV is navigating the clinical and regulatory pathway to bring this innovative, device-based therapy to a large, underserved patient population.
View full company profile